600200 logo

JiangSu WuZhong Pharmaceutical Development Co., Ltd. Stock Price

SHSE:600200 Community·CN¥203.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

600200 Share Price Performance

CN¥0.29
-6.53 (-95.75%)
CN¥0.29
-6.53 (-95.75%)
Price CN¥0.29

600200 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Undervalued with high growth potential.

3 Risks
3 Rewards

JiangSu WuZhong Pharmaceutical Development Co., Ltd. Key Details

CN¥1.1b

Revenue

CN¥394.0m

Cost of Revenue

CN¥706.2m

Gross Profit

CN¥768.3m

Other Expenses

-CN¥62.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.088
64.19%
-5.64%
84.0%
View Full Analysis

About 600200

Founded
1994
Employees
1096
CEO
Qunshan Qian
WebsiteView website
www.600200.com

JiangSu WuZhong Pharmaceutical Development Co., Ltd. engages in pharmaceutical, medical cosmetology, investment, and other industries in China and internationally. It provides genetic and chemical drugs in the fields of anti-virus, anti infection, immune regulation, anti-tumor, digestive system, cardiovascular, etc.; and modern traditional Chinese medicine. The company also offers high-end injection filling products for medical cosmetology. It offers its products in various forms, such as hard capsules, granules, tablets, oral solutions, dropping pills, emulsions, large-volume injections, and small-volumes injections, powder injections, freeze-dried powder injections and raw materials, and other dosage forms. The company was founded in 1994 and is based in Suzhou, China.

Recent 600200 News & Updates

Recent updates

No updates